H
Harpaul S. Gill
Researcher at Emory University
Publications - 8
Citations - 74
Harpaul S. Gill is an academic researcher from Emory University. The author has contributed to research in topics: Myeloid leukemia & Cancer. The author has an hindex of 4, co-authored 8 publications receiving 54 citations.
Papers
More filters
Journal ArticleDOI
Toxicities of systemic agents in squamous cell carcinoma of the head and neck (SCCHN); A new perspective in the era of immunotherapy
Nabil F. Saba,Mayur D. Mody,Elaine S. Tan,Harpaul S. Gill,Alessandra Rinaldo,Robert P. Takes,Primož Strojan,Dana M. Hartl,Dana M. Hartl,Jan B. Vermorken,Missak Haigentz,Alfio Ferlito +11 more
TL;DR: An overview of the toxicity profile of the different systemic agents is provided and a perspective into the future of SCCHN treatment is provided.
Journal ArticleDOI
Efficacy and safety of immune checkpoint blockade in self‐identified Black patients with advanced non–small cell lung cancer
Bassel Nazha,Subir Goyal,Zhengjia Chen,Anne Engelhart,Jennifer W Carlisle,Tyler Beardslee,Harpaul S. Gill,Levani Odikadze,Yuan Liu,Manoj K. Mishra,Suresh S. Ramalingam,Taofeek K. Owonikoko +11 more
TL;DR: Race‐based differences in efficacy for the treatment of patients with advanced non–small cell lung cancer have not been studied to date due to the underrepresentation of patients of minority backgrounds in pivotal trials, but real‐world differences in outcome in a diverse patient population are examined.
Journal ArticleDOI
The Evolving and Future Role of Taxanes in Squamous Cell Carcinomas of the Head and Neck: A Review.
TL;DR: An overview of the evidence thus far supporting the use of taxanes in the concurrent, induction, and adjuvant settings, as well as their use in the treatment of recurrent or metastatic SCCHN, and an analytical discussion of the projected future role of taxane in the management ofSCCHN.
Journal ArticleDOI
The Future Prospects of Immune Therapy in Gastric and Esophageal Adenocarcinoma.
TL;DR: This review plans to highlight the mechanisms, preclinical, and early clinical data that provide insight on the role of immune therapeutics in esophageal cancers.
Journal ArticleDOI
Complete Remission of Acute Myeloid Leukemia following Cisplatin Based Concurrent Therapy with Radiation for Squamous Cell Laryngeal Cancer
TL;DR: A patient simultaneously diagnosed with AML and squamous cell carcinoma of the larynx, who was found to be in complete remission from AML following treatment with cisplatin based chemoradiotherapy for his laryngeal cancer is presented.